MGRX
MGRX
NASDAQ · Retail

Mangoceuticals Inc

$0.37
-0.01 (-3.03%)
Financial Highlights (FY 2026)
Revenue
777.7K
Net Income
-35,186,344
Gross Margin
54.9%
Profit Margin
-4,526.8%
Rev Growth
+270.9%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 54.9% 61.9% 61.9% 61.9%
Operating Margin -4,504.2% 6.5% 7.0% 6.0%
Profit Margin -4,526.8% 5.0% 4.5% 3.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 777.7K 5.11M 4.81M 4.75M
Gross Profit 427.0K 3.17M 2.98M 2.94M
Operating Income -35,028,287 329.9K 336.3K 284.7K
Net Income -35,186,344 256.0K 217.7K 186.7K
Gross Margin 54.9% 61.9% 61.9% 61.9%
Operating Margin -4,504.2% 6.5% 7.0% 6.0%
Profit Margin -4,526.8% 5.0% 4.5% 3.9%
Rev Growth +270.9% +16.3% +24.4% +7.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 1.50M 1.33M 1.63M
Total Equity 4.93M 5.02M 5.16M
D/E Ratio 0.30 0.27 0.32
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -33,097,069 529.0K 487.2K 485.9K
Free Cash Flow 212.8K 148.5K 125.6K